Daisuke Usui
Fortuna: 213 932 $ al 31/05/2026
Fortuna: 213 932 $ al 31/05/2026
Daisuke Usui currently works at ReproCELL, Inc., as Chief Operating Officer & Director from 2020, RC Partners, Inc., as Director from 2016, ReproCELL Europe Ltd., as Director from 2016, and MAGiQ Therapeutics KK, as Director from 2019.
Mr. Usui also formerly worked at Reinnervate Ltd., as Chief Executive Officer.
Mr. Usui received his undergraduate degree from the University of Tsukuba.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REPROCELL INC. 0,28 % | 31/03/2025 | 264.000 ( 0,28 % ) | 213 932 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| REPROCELL INCORPORATED | Director de Operaciones | 11/11/2020 |
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance Engages in the operation and management of investment funds | Director/Miembro de la Junta | 01/06/2016 |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a human tissue research facility | Director/Miembro de la Junta | 01/07/2016 |
MAGiQ Therapeutics KK
MAGiQ Therapeutics KK Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Director/Miembro de la Junta | 01/12/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
Reinnervate Ltd.
Reinnervate Ltd. BiotechnologyHealth Technology Operates as a life sciences company which manufactures and distributes three dimensional cell culture products | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
University of Tsukuba
University of Tsukuba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reinnervate Ltd.
Reinnervate Ltd. BiotechnologyHealth Technology Operates as a life sciences company which manufactures and distributes three dimensional cell culture products | Health Technology |
ReproCELL, Inc.
ReproCELL, Inc. Medical SpecialtiesHealth Technology Engages in the reagents for ES/iPS and stem cell-derived functional cells | Health Technology |
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance Engages in the operation and management of investment funds | Finance |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a human tissue research facility | Commercial Services |
MAGiQ Therapeutics KK
MAGiQ Therapeutics KK Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.